Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to learn if Irbesartan is superior to placebo
in reducing mortality and cardiovascular morbidity in subjects with heart failure with
preserved systolic function. The safety of this treatment will also be studied.